PhRMA Honors Gardasil(r) Researchers With Discove... ( SAN ANTONIO Texas April 4 -- The Pha...)

PhRMA Honors Gardasil(r) Researchers With Discoverers Award

Date:4/4/2009

SAN ANTONIO, Texas, April 4 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) will honor recipients of its 2009 Discoverers Award and 2009 Clinical Trial Exceptional Service Award tonight at PhRMA's annual meeting in San Antonio, TX.

The awards will be presented to biopharmaceutical company scientists and other researchers who helped discover, develop and advance Gardasil(r), a breakthrough vaccine from Merck & Co., Inc. that can help prevent cervical cancer. (See footnote for more detailed description.) Cancer vaccines represent an emerging type of biological therapy.

With 500,000 new cases of cervical cancer and 250,000 deaths from it each year worldwide, human papillomavirus (HPV) infections and the resulting cancers are a major human health threat. HPV infection typically occurs in adolescent and young adult women.

"The recipients of these awards should all be proud that they have played such an incredible role in advancing healthcare here in America and around the world. Millions of patients will live healthier, longer lives because of the critical research that was done by these dedicated researchers," says PhRMA President and CEO Billy Tauzin. "These extraordinary honorees certainly deserve this recognition because they are the heroes behind a medicine that helps patients prevent a life-threatening cancer before it can get started."

PhRMA's Discoverers Award recognizes scientists whose research and development of medicines have greatly benefited mankind, and whose dedication to improving the quality of patients' lives exemplifies the best among research-based company scientists today.

Discoverers Award recipients are Merck's Eliav Barr, M.D., Vice President, Oncology Clinical Research, who led the team that developed Gardasil's clinical program; Merck's Barry Buckland, Ph.D., Vice President, Research, Bioprocess R&D,
'/>"/>

0

GOOD

Page: 1 2 3
Related medicine news :

1. PhRMA Statement on Enactment of FDA Legislation
2. PhRMA Celebrates 20th Anniversary of Discoverers Award
3. PhRMA Applauds House Committee on Foreign Affairs Commitment to Continuing Efforts to Fight AIDS, Tuberculosis, and Malaria Epidemics
4. Richard T. Clark Elected PhRMA Board Chairman
5. PhRMA Revised Marketing Code Reinforces Commitment to Responsible Interactions With Healthcare Professionals
6. Johnson & Johnson Announces Commitment To Adopt Revised PhRMA Marketing Code for Responsible Interactions With Healthcare Professionals
7. Eisai Renews Its Commitment to Responsible Healthcare Community Interactions in Accordance with the Revised PhRMA Marketing Code
8. Revised PhRMA Marketing Code Calls for More Educational Materials for Health Care Providers and Staff - Anatstat Health Education Can Help
9. DIA/FDA/PhRMA Drug Safety Conference: Planning the Lifecycle of Safety Evaluation
10. PhRMA Statement on Expansion of SCHIP
11. AstraZenecas David Brennan Elected PhRMA Board Chairman

Post Your Comments:

PhRMA Honors Gardasil(r) Researchers With Discove...( SAN ANTONIO Texas April 4 -- The Pha...),Health